Want to see DCGO full AI Analyst Report?
DCGO Stock Chart & Stats
$0.65
-$0.06(-1.42%)
At close: 4:00 PM EST
$0.65
-$0.06(-1.42%)
Day’s Range― - ―
52-Week Range$0.45 - $1.78
Previous CloseN/A
Volume125.49K
Average Volume (3M)1.05M
Market Cap
$59.30M
Enterprise Value$48.76M
Total Cash (Recent Filing)$35.68M
Total Debt (Recent Filing)$28.51M
Price to Earnings (P/E)―
Beta1.49
Next Earnings
Aug 10, 2026EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.91
Shares Outstanding98,778,410
10 Day Avg. Volume1,696,661
30 Day Avg. Volume1,054,002
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.60
Price to Sales (P/S)0.27
P/FCF Ratio3.22
Enterprise Value/Market Cap0.82
Enterprise Value/Revenue0.16
Enterprise Value/Gross Profit0.55
Enterprise Value/Ebitda-0.31
Forecast
1Y Price Target
$2.38Price Target Upside265.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.33
Revenue Forecast (FY)$298.67M
Bulls Say, Bears Say
Bulls Say
Manageable LeverageLow reported debt-to-equity provides durable financial flexibility: it reduces refinancing risk and gives the company capacity to fund operational turnarounds, working-capital needs, or tuck-in investments without immediate reliance on costly external debt or dilutive equity, supporting multi-quarter recovery plans.
Stable Gross MarginsA consistent ~30% gross margin across service lines indicates underlying unit economics remain intact. That durability means revenue scale can translate to operating leverage if SG&A is controlled, enabling sustainable margin improvement as mobile health and transport volumes rise and automation initiatives take effect.
Record Volumes And Raised GuidanceManagement reports sustained, broad-based volume growth and a higher full-year revenue outlook, supported by SteadyMD acceleration and contract renewals. This demonstrates structural market demand and multi-channel revenue expansion that can underpin medium-term top-line growth and scale benefits if margins recover.
Bears Say
Cash-flow CollapseA sharp swing to large negative operating and free cash flow is a material structural risk: sustained cash burn can force reliance on new financing, constrain capital allocation, hamper investment in growth initiatives, and amplify liquidity pressure over multiple quarters if collections and working-capital normalcy aren’t restored.
Profitability DeteriorationThe move from modest profits to significant losses undermines retained capital and investor optionality. Continued adjusted EBITDA losses compress reinvestment capacity, erode equity, and make achieving sustainable returns harder absent structural cost reductions or lasting margin recovery, posing a medium-term solvency risk.
Reliance On One-offs & Transitional CostsRevenue and margin visibility is weakened by reliance on lumpy or wind‑down items and an acquisition in transition. One-off migrant revenues and near-term SteadyMD incentives compress margins and make organic growth durability uncertain until transitional costs subside and new contracts consistently replace prior one-offs.
DocGo News
DCGO FAQ
What was DocGo, Inc.’s price range in the past 12 months?
DocGo, Inc. lowest stock price was $0.45 and its highest was $1.78 in the past 12 months.
What is DocGo, Inc.’s market cap?
DocGo, Inc.’s market cap is $59.30M.
When is DocGo, Inc.’s upcoming earnings report date?
DocGo, Inc.’s upcoming earnings report date is Aug 10, 2026 which is in 30 days.
How were DocGo, Inc.’s earnings last quarter?
DocGo, Inc. released its earnings results on May 11, 2026. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.122 by -$0.028.
Is DocGo, Inc. overvalued?
According to Wall Street analysts DocGo, Inc.’s price is currently Undervalued.
Does DocGo, Inc. pay dividends?
DocGo, Inc. does not currently pay dividends.
What is DocGo, Inc.’s EPS estimate?
DocGo, Inc.’s EPS estimate is -0.1.
How many shares outstanding does DocGo, Inc. have?
DocGo, Inc. has 98,778,410 shares outstanding.
What happened to DocGo, Inc.’s price movement after its last earnings report?
DocGo, Inc. reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.122. Following the earnings report the stock price went up 0.507%.
Which hedge fund is a major shareholder of DocGo, Inc.?
Currently, no hedge funds are holding shares in DCGO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DocGo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.38 (265.38% Upside)
$2.38 (265.38% Upside)
Blogger Sentiment
Bullish
DCGO Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 125.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.53%
12-Months-Change
Fundamentals
Return on Equity
-88.97%
Trailing 12-Months
Asset Growth
-51.43%
Trailing 12-Months
Company Description
DocGo, Inc.
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
DCGO Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mix of strong top‑line momentum and operational wins (raised full‑year revenue outlook, record volumes, SteadyMD acceleration, mobile phlebotomy and care‑gap scale) balanced against meaningful near‑term profitability and cash challenges (wider adjusted EBITDA loss, margin headwinds from fuel and temporary labor incentives, and $13M of outstanding receivables). Management expects many of the margin and expense pressures to be temporary and the majority of cost savings to flow through by Q3, while growth initiatives and contract renewals support the updated revenue guidance.View all DCGO earnings summariesDCGO Stock 12 Month Forecast
Average Price Target
$2.38
▲(265.38% Upside)
Technical Analysis
Ownership Overview
6.99% Insiders
8.26% Mutual Funds
0.34% Other Institutional Investors
79.21% Public Companies and
Individual Investors